Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Park, W.; Kasi, A.; Spira, A. I.; Berlin, J. D.; Wang, J. S.; Herzberg, B.; Kuboki, Y.; Kitano, S.; Pelster, M.; Goldman, J. W.; Morgensztern, D.; Kondo, S.; Jänne, P. A.; Fujii, H.; Lee, H. J.; Gill, S.; Saci, A.; Lorusso, P.; Tolcher, A. W. |
| Abstract Title: | Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC) |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S486 |
| End Page: | S487 |
| Language: | English |
| ACCESSION: | WOS:001326612900602 |
| DOI: | 10.1016/j.annonc.2024.08.675 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 608O -- Source: Wos |
